ZTS

#307
ZOETIS INC.
119.9700 USD
+0.54%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
119.5600
120.0600
Jahresspanne
113.3100
147.9000
Tagesänderung
+0.54%
Monatliche Änderung
+3.83%
6 month change
-18.01%
Jahresänderung
-18.01%
Vorheriger Schlusskurs
119.3300
Eröffnung
119.5600
Bid
Ask
Tief
119.5600
High
120.0600
Volumen
79
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 50.6427 B
  • Employee 15 K
  • Founded N/A
  • CEO Kristin C. Peck
  • Website www.zoetis.com
  • Headquarter New Jersey, United States
  • FIGI BBG0039320N9
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
20.9
Preis-Umsatz-Verhältnis
5.9
Dividende je Aktie
2.03
Dividendenrendite in %
1.61

Zoetis Inc Class A

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

Nachrichten